 |
|
Cyclin D1 and p53 Overexpression Predicts Multiple Primary Malignant Neoplasms of the Hypopharynx and Esophagus
Takahide Kohmura, MD;
Yasuhisa Hasegawa, MD;
Tetsuya Ogawa, MD;
Hidehiro Matsuura, MD;
Masakatsu Takahashi, MD;
Noriyuki Yanagita, MD;
Tsutomu Nakashima, MD
Arch Otolaryngol Head Neck Surg. 1999;125:1351-1354.
Background Multiple primary upper aerodigestive tract carcinomas can occur in up to 15% of patients. We have shown previously that half of the patients with multiple upper aerodigestive tract squamous cell carcinomas are initially seen with synchronous tumors. Most metachronous squamous cell carcinomas become manifest within 3 years.
Objective To examine the expression of 2 proteins—cyclin D1 and p53—in an attempt to predict the occurrence of multiple primary malignant neoplasms (MPs).
Materials and Methods Monoclonal antibodies to cyclin D1 (DCS-6 [dilution, 1:50], Novocastra Laboratories Ltd, Newcastle, England) and p53 (DO-7 [dilution, 1-100], Dako Corp, Carpinteria, Calif) proteins were used. Resection specimens from a total of 47 patients, 12 patients with MP and 35 patients with nonmultiple primary malignant neoplasms, were analyzed. Those in the nonmultiple primary malignant neoplasm group had longer than 3 years' follow-up to ascertain the absence of MP.
Results Tumor overexpression of cyclin D1 was significantly associated with the development of MP (P<.01). Tumor overexpression of p53 was also frequent in patients with MP although statistical significance was not achieved. The combination of these 2 parameters was an even greater predictor of MP (P<.001).
Conclusions Overexpression of cyclin D1 and p53 proteins was highly correlated with the development of MP. Additional studies are neccesary to confirm this finding. Immunohistochemical evaluation of primary squamous cell carcinomas for cyclin D1 and p53 overexpression may become an important fact of surgical pathologic reporting for primary upper aerodigestive tract squamous cell carcinomas.
From the Department of Otolaryngology, Nagoya University School of Medicine (Drs Kohmura, Takahashi, Yanagita, and Nakashima), Department of Head and Neck Surgery, Aichi Cancer Center Hospital (Drs Hasegawa and Matsuura), Nagoya, Japan; and Department of Otolaryngology, Gifu University School of Medicine, Gifu, Japan (Dr Ogawa).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region
Muto et al.
Carcinogenesis 2005;26:1008-1012.
ABSTRACT
| FULL TEXT
|
